Your account is not claimed yet. You can sign up with ORCID to claim your account.

Jean-François Yale (Jean-Francois Yale)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 15

Top Venues

Diabetes, obesity & metabolism

Diabetes therapy : research, treatment and education of diabetes and related disorders

Nature medicine

PloS one

McGill University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

McGill University Jul 1o 1985

Canada

Professor of endocrinology :: Medicine

Publications

Natalia McInnes, Stephanie Hall, Heather A Lochnan, Stewart B Harris, Zubin Punthakee, Ronald J Sigal, Irene Hramiak, Mohammed Azharuddin, Joanne F Liutkus, Jean-François Yale, Farah Sultan, Ada Smith, Rose E Otto, Diana Sherifali, Yan Yun Liu, Ulagamadesan Venkatesan, null null
Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial. Diabetes, obesity & metabolism (2023)
Irene Hramiak, Ulagamadesan Venkatesan, Lawrence Alan Leiter, Jean-François Yale, Harpreet S Bajaj, John Stewart, Marie-Josée Toutounji, Stewart B Harris
Comparing a daily versus weekly titration algorithm in people with type 2 diabetes switching from basal insulin to iGlarLixi in the LixiLan ONE CAN randomized trial. Diabetes, obesity & metabolism 24 (10) (2022)
Jean-François Yale, Beatrice Osumili, Beth D Mitchell, Barnaby Hunt, Gurjeev Sohi, Mark Jeddi, Donna Mojdami, William J Valentine
Evaluation of the cost and medical resource use outcomes associated with nasal glucagon versus injectable glucagon for treatment of severe hypoglycemia in people with diabetes in Canada: a modeling analysis. Journal of medical economics 25 (1) (2022)
Jean-François Yale, Aude Roborel de Climens, Naresh Aggarwal, Terry Dex, Ulagamadesan Venkatesan, Stewart B Harris, Irene Hramiak, John Stewart, Lawrence Alan Leiter
Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers. Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)
Jean-François Yale, Ulrik Bodholdt, Andrei-Mircea Catarig, Sergiu-Bogdan Catrina, Alice Clark, Neda Rajamand Ekberg, Umut Erhan, Patrick Holmes, Søren Tang Knudsen, Joanne Liutkus, Thozhukat Sathyapalan, Bernd Schultes, Gottfried Rudofsky
Real-world use of once-weekly semaglutide in patients with type 2 diabetes: pooled analysis of data from four SURE studies by baseline characteristic subgroups. BMJ open diabetes research & care 10 (2) (2022)
Jean-François Yale, Aude Roborel de Climens, Naresh Aggarwal, Terry Dex, Ulagamadesan Venkatesan, Stewart B Harris, Irene Hramiak, John Stewart, Lawrence Alan Leiter
Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers. Diabetes therapy : research, treatment and education of diabetes and related disorders 14 (2) (2022)
Jean-François Yale, Aude Roborel de Climens, Naresh Aggarwal, Terry Dex, Ulagamadesan Venkatesan, Stewart B Harris, Irene Hramiak, John Stewart, Lawrence Alan Leiter
Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers. Diabetes therapy : research, treatment and education of diabetes and related disorders 14 (2) (2022)
Jean-François Yale, Aude Roborel de Climens, Naresh Aggarwal, Terry Dex, Ulagamadesan Venkatesan, Stewart B Harris, Irene Hramiak, John Stewart, Lawrence Alan Leiter
Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers. Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)
Ahmad Haidar, Leif Erik Lovblom, Nancy Cardinez, Nikita Gouchie-Provencher, Andrej Orszag, Michael A Tsoukas, C Marcelo Falappa, Adnan Jafar, Milad Ghanbari, Devrim Eldelekli, Joanna Rutkowski, Jean-François Yale, Bruce A Perkins
Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial. Nature medicine 28 (6) (2022)
Michael A Tsoukas, Elisa Cohen, Laurent Legault, Julia E von Oettingen, Jean-François Yale, Michael Vallis, Madison Odabassian, Anas El Fathi, Joanna Rutkowski, Adnan Jafar, Milad Ghanbari, Nikita Gouchie-Provencher, Jennifer René, Emilie Palisaitis, Ahmad Haidar
Alleviating carbohydrate counting with a FiASP-plus-pramlintide closed-loop delivery system (artificial pancreas): Feasibility and pilot studies. Diabetes, obesity & metabolism 23 (9) (2021)
Ahmad Haidar, Jean-François Yale, Leif Erik Lovblom, Nancy Cardinez, Andrej Orszag, C Marcelo Falappa, Nikita Gouchie-Provencher, Michael A Tsoukas, Anas El Fathi, Jennifer Rene, Devrim Eldelekli, Sebastien O Lanctôt, Daniel Scarr, Bruce A Perkins
Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trial. Diabetes, obesity & metabolism 23 (6) (2021)
Jean-François Yale, Andrei-Mircea Catarig, Katrine Grau, Stewart Harris, Agnieszka Klimek-Abercrombie, Remi Rabasa-Lhoret, Laura Reardon, Vincent Woo, Joanne Liutkus
Use of once-weekly semaglutide in patients with type 2 diabetes in routine clinical practice: Results from the SURE Canada multicentre, prospective, observational study. Diabetes, obesity & metabolism 23 (10) (2021)
Ronald M Goldenberg, Peter Assimakopoulos, Jeremy D Gilbert, Irving S Gottesman, Jean-François Yale
A practical approach and algorithm for intensifying beyond basal insulin in type 2 diabetes. Diabetes, obesity & metabolism 20 (9) (2018)
Riccardo C Bonadonna, Jean-François Yale, Claire Brulle-Wohlhueter, Emmanuelle Boëlle-Le Corfec, Pratik Choudhary, Timothy S Bailey
Hypoglycaemia as a function of HbA1c in type 2 diabetes: Insulin glargine 300 U/mL in a patient-level pooled analysis of EDITION 1, 2 and 3. Diabetes, obesity & metabolism 21 (3) (2018)
Jean-François Yale, Jeremy Hodson Pettus, Miguel Brito-Sanfiel, Fernando Lavalle-Gonzalez, Ana Merino-Trigo, Peter Stella, Soazig Chevalier, Raffaella Buzzetti
The effect of concomitant DPPIVi use on glycaemic control and hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus insulin glargine 100 U/mL (Gla-100) in people with type 2 diabetes: A patient-level meta-analysis of EDITION 2 and 3. PloS one 13 (1) (2018)

Jean-François Yale.css-eqlu8i{font-size:small;padding-left:4px;} (Jean-Francois Yale)

Publication Activity (10 Years)

Top Topics

Top Venues

Jean-François Yale (Jean-Francois Yale)